Latest on Coronavirus

• Moderna teams up with ROVI to provide Covid-19 vaccine outside US

  Moderna has partnered with European pharmaceutical company ROVI for finish-fill manufacturing of its Covid-19 vaccine candidate, mRNA-1273.
• Emergent BioSolutions and partners to develop Covid-19 therapy

  Emergent BioSolutions has partnered with the Mount Sinai Health System and ImmunoTek Bio Centers on its Covid-19 hyperimmune globulin candidate, COVID-HIG.
• Intellectual property in the time of Covid-19

• Russia approves R-Pharm’s Coronavir for Covid-19 treatment

  Russian pharmaceutical company R-Pharm has secured regulatory approval for the use of its antiviral drug Coronavir, to treat patients with Covid-19.
• CEPI expands Covid-19 vaccine alliance with Clover Biopharmaceuticals

  The CEPI has expanded its collaboration with Sichuan Clover Biopharmaceuticals to speed-up the development and manufacture of Covid-19 vaccine candidate.
• US awards $450m contract to Regeneron for Covid-19 therapy supply

  Regeneron Pharmaceuticals has received a $450m contract from the US government for the manufacture and supply of its antibody cocktail against Covid-19.
• Covid-19: Synairgen embraces virtual clinical trials

  Synairgen has launched two studies of SNG001 for at-risk Covid-19 patients; one is an at-home virtual trial in those at earlier stages of the disease.
• GSK partners with Medicago to develop plant-based Covid-19 vaccine

  GlaxoSmithKline (GSK) has partnered with Medicago to develop, assess and manufacture a plant-based adjuvanted Covid-19 vaccine candidate.
• Novavax receives $1.6bn from US Government for Covid-19 vaccine

  Novavax has received $1.6bn from the US Government to support the development and manufacturing of its Covid-19 vaccine candidate.
• Mylan gets approval for emergency use of remdesivir for Covid-19

  Mylan has secured regulatory approval from the DCGI for restricted emergency use of 100mg/vial remdesivir lyophilized powder to treat Covid-19.